Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2006-12-19
2006-12-19
Bockelman, Mark (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C604S891100, C604S066000
Reexamination Certificate
active
07151961
ABSTRACT:
Introducing one or more stimulating drugs to the brain and/or applying electrical stimulation to the brain is used to treat movement disorders. At least one implantable system control unit (SCU) produces electrical pulses delivered via electrodes implanted in the brain and/or drug infusion pulses delivered via a catheter implanted in the brain. The stimulation is delivered to targeted brain structures to adjust the activity of those structures. In some embodiments, one or more sensed conditions are used to adjust stimulation parameters.
REFERENCES:
patent: 4702254 (1987-10-01), Zabara
patent: 4867164 (1989-09-01), Zabara
patent: 5025807 (1991-06-01), Zabara
patent: 5193539 (1993-03-01), Schulman et al.
patent: 5193540 (1993-03-01), Schulman et al.
patent: 5312439 (1994-05-01), Loeb
patent: 5683422 (1997-11-01), Rise
patent: 5707396 (1998-01-01), Benabid
patent: 5711316 (1998-01-01), Elsberry et al.
patent: 5716377 (1998-02-01), Rise et al.
patent: 5792186 (1998-08-01), Rise
patent: 5832932 (1998-11-01), Elsberry et al.
patent: 5833709 (1998-11-01), Rise et al.
patent: 6013449 (2000-01-01), Fischell et al.
patent: 6051017 (2000-04-01), Loeb et al.
patent: 6094598 (2000-07-01), Elsberry et al.
patent: 6205359 (2001-03-01), Boveja
patent: 6227203 (2001-05-01), Rise et al.
patent: 6356784 (2002-03-01), Lozano et al.
patent: 6415184 (2002-07-01), Ishikawa et al.
patent: 6463328 (2002-10-01), John
patent: 6464687 (2002-10-01), Ishikawa et al.
patent: 6788975 (2004-09-01), Whitehurst et al.
patent: 2001/0003799 (2001-06-01), Boveja
patent: 2002/0013612 (2002-01-01), Whitehurst
patent: 2002/0161403 (2002-10-01), Meadows et al.
patent: 2003/0036780 (2003-02-01), Barrett et al.
patent: WO-98/37926 (1998-02-01), None
patent: WO-98/43700 (1998-03-01), None
patent: WO-98/43701 (1998-03-01), None
patent: WO-00/38669 (2000-07-01), None
patent: WO-00/38669 (2000-07-01), None
Benabid, et al., “Long-Term Suppression of Tremor by Chronic Stimulation of the Ventral Intermediate Thalamic Nucleus”, Lancet, vol. 337(8738), (Feb. 16, 1991), pp. 403-406.
Bradley, et al., “Activation of Group II Metabotropic Glutamate Receptors Inhibits Synaptic Excitation of the Substantia Nigra Pars Reticulata”, The Journal of Neuroscience, vol. 20(9), (May 1, 2000), pp. 3085-3094.
Cameron, et al., “Micromodular Implants to Provide Electrical Stimulation of Paralyzed Muscles and Limbs”, IEEE Transactions on Biomedical Engineering, vol. 44, No. 9, (Sep. 1997), pp. 781-790.
Gill, et al. “Direct Brain Infusion of Glial Cell Line-Derived Neurotrophic Factor in Parkinson Disease”, Nature Medicine, Advance Online Publication, (Mar. 31, 2003).
Handforth, et al., “Effect of Vagus Nerve Stimulation on Essential Tremor”, Neurology, vol. 54 Suppl. 3, (2000), pp. A238.
Handforth, et al., “Suppression of Harmaline-Induced Tremor in Rats by Vagus Nerve Stimulation”, Movement Disorders, vol. 16(1), (Jan. 2001), pp. 84-88.
Hooper, et al., “A Prospective Study of Thalamic Deep Brain Stimulation for the Treatment of Movement Disorders in Multiple Sclerosis”, British Journal of Neurosurgery, vol. 16, No. 2 (Apr. 1, 2002), pp. 102-109.
Levy, et al. “Effects of Apomorphine on Subthalamic Nucleus and Globus Pallidus Internus Neurons in Patients with Parkinson's Disease.” Journal of Neurophysiology, vol. 86(1), (Jul. 2001), pp. 249-260.
Stefani, et al., “Subdyskinetic Aomorphine Responses in Globus Pallidus and Subthalamus of Parkinsonian Patients: Lack of Clear Evidence for the ‘Indirect Pathway’.” Clinical Neurophysiology, vol. 113(1), (Jan. 2002), pp. 91-100.
Walker, et al., “Regulation of Limbic Motor Seizures by GABA and Glutamate Transmission in Nucleus Tractus Solitarius”, Epilepsia, vol. 40(8), (Aug. 1999), pp. 1051-1057.
Whitehurst, McGivern, and Kuzma inventors for AB-116U; U.S. Appl. No. 10/081,820; filed Feb. 19, 2002; entitled “Fully Implantable Miniature Neurostimulator for Vagus Nerve Stimulation”.
Whitehurst and McGivern inventors for AB-134U; U.S. Appl. No. 10/224,021; filed Aug. 19, 2002; entitled “Treatment of Movement Disorders by Extradural Motor Cortex Stimulation”.
Whitehurst, McGivern, and Kuzma inventors for AB-210U; U.S. Appl. No. 10/057,115; filed Jan. 24, 2002; entitled “Fully Implantable Miniature Neurostimulator for Stimulation as a Therapy for Epilepsy”.
Whitehurst inventor for AB-223U; U.S. Appl. No. 10/428,743; filed May 2, 2003; entitled “Treatment of Epilepsy by Brain Stimulation”.
McClure Kelly H
McGivern James P
Whitehurst Todd K
Advanced Bionics Corporation
Bishop Laura Haburay
Bockelman Mark
LandOfFree
Treatment of movement disorders by brain stimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of movement disorders by brain stimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of movement disorders by brain stimulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3717455